Cargando...
Novel strategies to target the ubiquitin proteasome system in multiple myeloma
Multiple myeloma (MM) is a hematological malignancy characterized by the accumulation of plasma cells in the bone marrow (BM). The success of the proteasome inhibitor bortezomib in the treatment of MM highlights the importance of the ubiquitin proteasome system (UPS) in this particular cancer. Despi...
Guardado en:
| Publicado en: | Oncotarget |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Impact Journals LLC
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4872730/ https://ncbi.nlm.nih.gov/pubmed/26695547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6658 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|